Report post Feedback

What is G1 Therapeutics?

G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA® (trilaciclib).

What is G1 doing now?

G1 is also executing a development program, with late-stage clinical trials ongoing in combination with cytotoxic therapies and/or immunotherapy in areas of high unmet need including triple-negative breast cancer and extensive stage small cell lung cancer.

What is G1's clinical pipeline?

G1 has a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including breast, lung, and bladder cancers. Data Provided by Refinitiv. Minimum 15 minutes delayed.

Who is the Chief Business Officer of G1?

Mr. Avagliano joined G1 as Chief Business Officer in 2019. In this role, he is responsible for leading the company’s global partnering and corporate development strategy and execution. Mr.

The World's Leading Crypto Trading Platform

Get my welcome gifts